Michael S. Aberman, VP Strategy and Investor Relat at REGENERON PHARMACEUTICALS INC (REGN), sold 12,500 shares at $69.57 ($828K) on 2011-09-07, disclosed to the SEC on 2011-09-07.
Scheduled sale ($828k) by VP Strategy and Investor Relat under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.00 | 4,166 | $267K | 32.2% |
| 2 | $65.76 | 1,916 | $126K | 15.2% |
| 3 | $65.76 | 3,041 | $200K | 24.2% |
| 4 | $67.39 | 200 | $13K | 1.6% |
| 5 | $68.80 | 700 | $48K | 5.8% |
| 6 | $69.57 | 900 |
| $63K |
| 7.6% |
| 7 | $70.39 | 1,577 | $111K | 13.4% |
| Total | $66.23 avg | 12,500 | $828K | 100% |
| Filing → |
| REGN | SELL | 2015-03-19 | $1.6M | — | Filing → |
| REGN | SELL | 2015-02-25 | $1.4M | — | Filing → |
| REGN | SELL | 2015-02-18 | $1.5M | — | Filing → |